Electrochemical DNA‐Based Biosensors for In Vivo Quantification of a Therapeutic Protein
Open Access
- 25 July 2026
- journal article
- research article
- Published by Wiley in Small Structures
- Vol. 7 (7) , e70539
Abstract
Inter‐subject pharmacokinetic variability limits the clinical effectiveness of many “biologics”, including monoclonal antibody drugs. This issue can be addressed through therapeutic drug monitoring (TDM), in which clinicians tailor dosing to individual patients based on measured plasma drug concentrations. In practice, TDM is inconvenient because current methods for quantifying protein drugs in blood are labor‐intensive and expensive. In response, here we present an electrochemical DNA‐based biosensor that addresses this issue by enabling rapid, reagentless measurement of plasma concentrations of the antibody drug trastuzumab. The approach supports real‐time, in vivo monitoring in living animals (rats). Specifically, we have systematically compared two distinct sensing architectures, a DNA scaffold sensor and an electrochemical aptamer‐based sensor, before developing an optimized sensor in the latter class that, when challenged in undiluted whole blood, can measure over the entire clinical range of the drug. When implanted in animals, the sensor successfully tracks in vivo drug concentrations and clearly visualizes differences in drug exposure between individual rats following intravenous infusion. Given the ability to generalize EAB sensors to almost any target of interest, this work illustrates a powerful new tool to guide real‐time dosing of biologic therapeutics, enabling personalized treatments of this increasingly important class of drugs.Keywords
This publication has 42 references indexed in Scilit:
- Continuous monitoring of biomolecular targets in vivo using DNA-based electrochemical sensorsCurrent Opinion in Electrochemistry, 2025
- The challenge of long-term stability for nucleic acid-based electrochemical sensorsCurrent Opinion in Electrochemistry, 2021
- Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncologyPharmacology Research & Perspectives, 2021
- The pharmacology and therapeutic applications of monoclonal antibodiesPharmacology Research & Perspectives, 2019
- Therapeutic drug monitoring of monoclonal antibodies: Applicability based on their pharmacokinetic propertiesDrug Metabolism and Pharmacokinetics, 2019
- Studying small molecule–aptamer interactions using MicroScale Thermophoresis (MST)Methods, 2016
- Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serumJournal of Immunological Methods, 2012
- Optical Thermophoresis for Quantifying the Buffer Dependence of Aptamer BindingAngewandte Chemie International Edition, 2010
- Label‐Free Electronic Detection of Thrombin in Blood Serum by Using an Aptamer‐Based SensorAngewandte Chemie, 2005
- Variability in Human Drug Metabolism1980